Corinne focuses on pharmaceuticals, biologics, biotechnology, and medical devices. She has worked on cases concerning DNA sequencing technologies, recombinant polypeptides, enzyme inhibitors, receptor agonists, iron chelators, anti-diabetic drugs, wakefulness-promoting agents, surgical mesh affixing systems, and laser hair removal systems.
Corinne edits, writes for, and manages Venable's BiologicsHQ microsite – a website that provides statistical analyses and timely commentary concerning U.S. patent proceedings relating to FDA-approved biologic drugs. She also regularly publishes and speaks on a wide variety of intellectual property topics and developments.
Corinne formerly practiced as a barrister in England and Wales, where she advised on high-value patent, trademark, and commercial litigation, and international arbitration matters.